Chondroitin sulphate-modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas-mediated pathway

EMBO Reports

Volumn 9, Issue 10, 2008, Pages 983-989

  Frankel, Paul ^a   Pellet Many, Caroline ^a   Lehtolainen, Pauliina ^a   D'Abaco, Giovanna M ^b   Tickner, Michelle L ^a   Cheng, Lili ^a   Zachary, Ian C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN ABC LYASE; CHONDROITIN SULFATE; CRK ASSOCIATED SUBSTRATE PROTEIN; NEUROPILIN 1; SMALL INTERFERING RNA; TUNICAMYCIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; GENE SILENCING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYME CELL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAT; TUMOR BIOPSY; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CHONDROITIN SULFATES; CRK-ASSOCIATED SUBSTRATE PROTEIN; GLIOBLASTOMA; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEUROPILIN-1; RATS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SWINE;

EID: 53249107550     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2008.151     Document Type: Article

References (28)

1. Ambrogio C et al (2005) p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. Blood 106: 3907-3916
2. Bachelder RE, Wendt MA, Mercurio AM (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62: 7203-7206
3. Bielenberg DR, Pettaway CA, Takashima S, Klagsbrun M (2006) Neuropilins in neoplasms: Expression, regulation, and function. Exp Cell Res 312: 584-593
4. Bourdon MA, Krusius T, Campbell S, Schwartz NB, Ruoslahti E (1987) Identification and synthesis of a recognition signal for the attachment of glycosaminoglycans to proteins. Proc Natl Acad Sci USA 84 3194-3198
5. Cheng L, Jia H, Lohr M, Bagherzadeh A, Holmes DI, Selwood D, Zachary I (2004) Anti-chemorepulsive effects of vascular endothelial growth factor and placental growth factor-2 in dorsal root ganglion neurons are mediated via neuropilin-1 and cyclooxygenase-derived prostanoid production. J Biol Chem 279: 30654-30661
6. Defilippi P, Di Stefano P, Cabodi S (2006) p130Cas: A versatile scaffold in signaling networks. Trends Cell Biol 16: 257-263
7. Denholm EM, Lin YQ, Silver PJ (2001) Anti-tumor activities of chondroitinase AC and chondroitinase B: Inhibition of angiogenesis, proliferation and invasion. Eur J Pharmacol 416: 213-221
8. Fukasawa M, Matsushita A, Korc M (2007) Neuropilin-1 interacts with integrin β1 and modulates pancreatic cancer cell growth, survival and invasion. Cancer Biol Ther 6: 1173-1180
9. Gu C, Rodriguez ER, Reimert DV, Shu T, Fritzsch B, Richards LJ, Kolodkin AL, Ginty DD (2003) Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell 5: 45-57
10. Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, Maitra A (2004) Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol 28: 347-356
11. He Z, Tessier-Lavigne M (1997) Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90: 739-751
12. Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O, Mikkelsen T, Hirose T, Nishikawa R, Cheng SY (2007) Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene 26: 5577-5586
13. Jia H et al (2006) Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling. J Biol Chem 281: 13493-13502
14. Kjellen L, Lindahl U (1991) Proteoglycans: Structures and interactions. Annu Rev Biochem 60: 443-475
15. Kokenyesi R, Bernfield M (1994) Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1. J Biol Chem 269: 12304-12309
16. Liu W, Litwack ED, Stanley MJ, Langford JK, Lander AD, Sanderson RD (1998) Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J Biol Chem 273: 22825-22832
17. Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, Cox BD, Wang W, Grammer JR, Gladson CL (2006) HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 25: 1721-1732
18. Osada H, Tokunaga T, Nishi M, Hatanaka H, Abe Y, Tsugu A, Kijima H, Yamazaki H, Ueyama Y, Nakamura M (2004) Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma. Anticancer Res 24: 547-552
19. Pan Q et al (2007) Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11 53-67
20. Sahai E (2005) Mechanisms of cancer cell invasion. Curr Opin Genet Dev 15: 87-96
21. Sahai E, Marshall CJ (2003) Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5: 711-719
22. Shintani Y et al (2006) Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J 25: 3045-3055
23. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735-745
24. Stan AC, Casares S, Radu D, Walter GF, Brumeanu TD (1999) Doxorubicin-induced cell death in highly invasive human gliomas. Anticancer Res 19: 941-950
25. Tester NJ, Plaas AH, Howland DR (2007) Effect of body temperature on chondroitinase ABC's ability to cleave chondroitin sulfate glycosaminoglycans. J Neurosci Res 85: 1110-1118
26. Theocharis AD, Tsolakis I, Tzanakakis GN, Karamanos NK (2006) Chondroitin sulfate as a key molecule in the development of atherosclerosis and cancer progression. Adv Pharmacol 53: 281-295
27. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Brocker EB, Friedl P (2003) Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160: 267-277
28. Yip GW, Smollich M, Gotte M (2006) Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther 5: 2139-2148